Starting at the earliest stages of life we are advantaged by co-location of strong maternal, fetal, neonatal and paediatric research groups. Established collaborations with the Maudsley BRC uniquely bridge the gap between maternal and child mental and physical health. Extensive interactions with NIHR Clinical Research Networks underpin translation of our research to those of greatest need; between January 2010 and March 2016, 11,630 of our local women and 14,107 children from the socially deprived Boroughs of Lambeth and Southwark participated in relevant NIHR network trials.
Supported by Cluster 2 (Precision Medicine) and Cluster 3 (Data Analytics) we shall continue to elucidate aetiological pathways, create precision medicine tools for risk stratification and diagnosis, and develop personalised interventions. This vision is strengthened by industrial partners Alere, Hologic and Medix Biochemica (diagnostic platforms); MicroLife (electronic devices) and Abbott Nutrition, Danone and Evolve Biosystems USA (nutritional/probiotic supplements), and through our Implementation Science team (Sandall). The PIs’ committed support for clinical, allied health professional and basic science training (intercalated BSc, MSc, PhDs, Clinical Research Fellows) will be reinforced through Cluster 4 (The School of Translational and Experimental Medicine).
Lucilla Poston NIHR Senior Investigator FMedSci
Professor of Women’s Health, Head, Division of Women’s Health, King’s; Director of Tommy’s Charity UK Centre for Maternal and Fetal Heath; Chair, Royal College of Obstetricians and Gynecologists Research Committee. Member Medical Research Council Population Sciences and Medicine Board and Global Health Group. Wellcome Trust Committees.